PRIMARY Trial world-first prospective study of PSMA-PET CT prior to diagnostic biopsy in men suspected of prostate cancer

Recently in 2020, Dr Thompson and colleagues published the trial design for a prospective, multicentre trial of Ga68-PSMA PET CT scans in combination with multi-parametric MRI scans to see if it is possible to improve the accuracy of detecting prostate cancer. MRI alone detects 85-90% but is unable to reliably detect all cancers; Dr Thompson and his research colleagues believe that combining MRI with PSMA scans may be able to detect up to 98-99% of cancers, such that most unnecessary prostate biopsies can be avoided.

A link to the study overview is below and enrolments are progressing well, so results are expected to be available in 2021.

https://bjui-journals.onlinelibrary.wiley.com/doi/abs/10.1111/bju.14999?af=R

Dr Thompson and colleagues publish important study of outcomes following salvage robotic surgery after failed focal HIFU ablation therapy

Large cohort of outcomes at 3 years following Nanoknife focal ablation therapy published in European Urology Oncology